OtherDevelopmental medicine and child neurology2026

Integrating transdiagnostic and holistic approaches in early neurodevelopmental screening.

Kahoko Yasumitsu-Lovell

PMID 41319098

WHAT IT FOUND

No new screening evidence is reported here.

The paper is a commentary on another study and reports no original methods or outcomes.

What this paper is

This is a commentary discussing a transdiagnostic neurodevelopmental screening study. It has no original methods or results, so there is no finding to act on.

The easy way to misread this

Do not read this as evidence that the MOS-R or HINE predicts cerebral palsy, autism, or fetal alcohol spectrum disorder. It is a commentary on another study and reports no original methods or results.

Summarised by AI from the full paper, without a clinician reviewing it. Check it against the source before it changes what you do. Read it on PubMed →


The study

Certainty of evidence
Low

Browse

    Cite

    Kahoko Yasumitsu-Lovell Integrating transdiagnostic and holistic approaches in early neurodevelopmental screening. Developmental medicine and child neurology. 2026.

    Read the original — we summarise, we never replace the paper.